Delaware Court Voids Mallinckrodt’s $9.5 Million Patent Award Amid Strategic Market Battle
In a recent legal maneuver, Mallinckrodt Pharmaceuticals faced a setback as a Delaware federal judge nullified a $9.5 million jury award in their favor. The award was initially granted in an infringement case concerning patented inhalation treatments. The ruling, delivered on Tuesday, involves a competitor’s inhaled nitric oxide treatment patent, now subject to delay until…